2016
DOI: 10.1016/j.breast.2015.10.004
|View full text |Cite
|
Sign up to set email alerts
|

Brain natriuretic peptide as a cardiac marker of transient radiotherapy-related damage in left-sided breast cancer patients: A prospective study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
36
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 48 publications
(37 citation statements)
references
References 36 publications
0
36
1
Order By: Relevance
“…28,29 Palumbo I et al confirmed that BNP could be a useful minimally invasive marker of early RT related cardiac impairment in left sided breast cancer. 30 However, no increase in BNP levels at any time point was observed following RT in our study.…”
contrasting
confidence: 47%
“…28,29 Palumbo I et al confirmed that BNP could be a useful minimally invasive marker of early RT related cardiac impairment in left sided breast cancer. 30 However, no increase in BNP levels at any time point was observed following RT in our study.…”
contrasting
confidence: 47%
“…In a study of 30 patients undergoing thoracic radiotherapy with chemotherapy, no significant elevations in troponin, nt-proBNP or creatine kinase-myocardial band (CK-MB) were observed after radiotherapy ( 58 ). However, recent studies suggest BNP may be useful as an acute marker of early radiotherapy-related cardiovascular impairment in left-sided breast cancer patients ( 59 ), and in patients receiving thoracic radiotherapy with high-dose heart exposure ( 59 , 60 ). Nevertheless, the majority of patients receiving greater than 20 Gy to the heart during thoracic radiotherapy did not exhibit increased levels of troponin I ( 60 ).…”
Section: Discussionmentioning
confidence: 99%
“…This fluctuation matches the results in the present study. Palumbo et al [6] found significant correlation between radiation dose to the heart and normalized BNP levels (a ratio compared to baseline BNP) up to 1 year after treatment, but no correlations with absolute BNP levels. They also did not find any change in the left ventricle ejection fraction; therefore, any changes in BNP are subclinical and may predict damage [6].…”
Section: Discussionmentioning
confidence: 99%
“…Palumbo et al [6] looked at BNP as a marker of radiotherapy-related damage in left-sided breast cancer patients. They found that BNP increased transiently 6 months after treatment, and decreased 1 year after treatment, but remained above baseline levels [6]. This fluctuation matches the results in the present study.…”
Section: Discussionmentioning
confidence: 99%